SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 39 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $74,000 | – | 12,804 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Newtyn Management, LLC | 415,000 | $942,000 | 0.18% |
RA Capital Management | 723,549 | $1,642,000 | 0.04% |
Duquesne Family Office | 100,000 | $227,000 | 0.02% |
LEO BROKERAGE, LLC | 14,845 | $34,000 | 0.01% |
Ergoteles LLC | 93,598 | $212,000 | 0.01% |
Virtu Financial LLC | 11,223 | $25,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 37,900 | $86,000 | 0.00% |
Renaissance Technologies | 247,000 | $561,000 | 0.00% |
UBS Group AG | 13,463 | $31,000 | 0.00% |
TWO SIGMA INVESTMENTS, LP | 38,776 | $88,000 | 0.00% |